Solvonis Therapeutics plc

SVNS.L · LSE
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-£2-£3-£3-£1
Dep. & Amort.£0£0£0£0
Deferred Tax£0£0-£2£0
Stock-Based Comp.£0£0£1£0
Change in WC-£0£0-£1£1
Other Non-Cash£0£1£2-£1
Operating Cash Flow-£1-£1-£2-£0
Investing Activities
PP&E Inv.-£0-£0-£1-£0
Net Acquisitions-£0£0£0£0
Inv. Purchases£0£0£0£0
Inv. Sales/Matur.£0£0£0£0
Other Inv. Act.-£0£0£0£0
Investing Cash Flow-£0-£0-£1-£0
Financing Activities
Debt Repay.£0£0£0£0
Stock Issued£2£0£4£1
Stock Repurch.£0£0£0£0
Dividends Paid£0£0£0£0
Other Fin. Act.-£0£0-£0£1
Financing Cash Flow£2£0£4£1
Forex Effect-£0-£0-£0£0
Net Chg. in Cash£1-£1£1£0
Supplemental Information
Beg. Cash£0£2£1£0
End Cash£1£0£2£1
Free Cash Flow-£1-£1-£3-£0